Financial Performance - The company's operating revenue for Q1 2025 reached CNY 1,980,800,986.57, representing a 113% increase compared to CNY 929,971,824.42 in the same period last year[4]. - Net profit attributable to shareholders was CNY 24,456,428.90, a significant recovery from a loss of CNY 47,795,282.00 in the previous year[4]. - Total operating revenue for Q1 2025 reached ¥1,980,800,986.57, a significant increase from ¥929,971,824.42 in Q1 2024, representing a growth of approximately 113%[17]. - Net profit for Q1 2025 was ¥22,767,023.83, a turnaround from a net loss of ¥48,181,193.48 in Q1 2024[19]. - The total profit for Q1 2025 was ¥31,245,995.93, compared to a total loss of ¥41,036,830.36 in the same period last year[28]. Cash Flow and Liquidity - The net cash flow from operating activities was negative at CNY -464,410,173.30, worsening from CNY -88,097,684.40 year-on-year[4]. - Cash inflow from operating activities totaled ¥1,630,447,097.35 in Q1 2025, up from ¥1,340,890,266.99 in Q1 2024[21]. - The net cash flow from operating activities was -464,410,173.30 RMB, a significant decline compared to -88,097,684.40 RMB in the previous period, indicating a worsening operational cash flow situation[22]. - Cash and cash equivalents at the end of the period were 1,736,701,380.19 RMB, down from 2,382,588,964.73 RMB, indicating a decrease of approximately 27%[22]. - Cash and cash equivalents at the end of Q1 2025 amounted to ¥1,278,412,405.45, down from ¥2,182,197,124.28 at the end of Q1 2024[31]. Research and Development - Research and development expenses totaled CNY 69,331,438.75, an increase of 77.34% from CNY 39,094,235.52, reflecting a stronger focus on new product and technology development[5]. - The company reported a significant increase in research and development expenses, which rose to ¥12,924,908.28 in Q1 2025 from ¥8,607,429.52 in Q1 2024, indicating a focus on innovation and product development[17]. - Research and development expenses increased to ¥10,651,862.55 in Q1 2025, up from ¥7,143,829.27 in Q1 2024, reflecting a focus on innovation[27]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 13,654,981,365.71, up 4.68% from CNY 13,044,744,141.71 at the end of the previous year[5]. - The total liabilities increased to ¥6,579,438,239.17 in the latest reporting period from ¥5,998,086,967.12 previously, marking an increase of about 10%[16]. - Total current assets increased to 8,333,283,111.39 RMB from 7,610,565,252.81 RMB, reflecting a growth of approximately 9.5%[24]. - The company's total liabilities rose to 5,597,127,803.96 RMB, up from 4,953,655,606.64 RMB, representing an increase of about 13%[25]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 16,310[10]. - The top shareholder, Shandong Jiayuan Industrial Investment Co., Ltd., holds 21.19% of the shares, totaling 90,300,270 shares[10]. - The company repurchased 3,684,100 shares, accounting for 0.86% of the total share capital[12]. - The top ten shareholders hold significant stakes, with the largest shareholder owning 90,300,270 shares, representing a substantial portion of the company's equity[11]. Strategic Outlook - The company plans to continue expanding its market presence and enhancing its product offerings through increased R&D investment[8]. - The company plans to continue focusing on market expansion and new product development as part of its growth strategy[32].
嘉元科技(688388) - 2025 Q1 - 季度财报